Success Story: Precision Medicine Research in Oncology Secures NIW Approval in Just 2 Months

Posted by wegreened on August 28, 2026 in NIW

Client’s Testimonial:

"I appreciated the thoroughness of my attorneys and the promptness of their replies. Overall, I am satisfied with the services I received and will happily recommend your firm to any colleagues who ask”

In July 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Resident Physician (Approval Notice).

Position at the Time of Case Filing: Resident Physician

Country of Origin: Pakistan

Approval Notice Date: July 2026

Processing Time: 2 months, 1 day (Premium Processing Requested)

Case Summary:

Recognizing the need for more accessible diagnostic tools, the client sought the assistance of North America Immigration Law Group (Chen Immigration Law Associates) to prepare an NIW petition centered on developing minimally invasive diagnostic platforms for complex oncologic disorders.

We framed the proposed endeavor as a long-term effort to transform how complex oncologic diseases are detected and monitored. The petition explained that combining advanced biomolecular analysis with computational biology could enable minimally invasive, real-time monitoring of disease progression, while improving diagnostic precision, reducing reliance on high-risk or invasive traditional procedures, and supporting more personalized treatment strategies. We also demonstrated how these innovations aligned with national initiatives promoting precision medicine and biotechnology while addressing clinical conditions that impose a significant healthcare and economic burden.

The petition further established that the client had already built a strong foundation for advancing this work. This experience was reflected in an impressive scholarly record that included 18 peer-reviewed journal articles, 4 conference abstracts, 4 preprints, 2 book chapters, 456 citations, and at least 11 completed peer reviews.

Equally important, we demonstrated that other researchers were actively building upon the client's discoveries. The client's publications helped advance the development of their field and strengthened research into precision immunotherapies and targeted cancer treatments. Several publications ranked among the most-cited Clinical Medicine papers of their publication years, including one within the top 0.1 percent, illustrating that the research had attracted substantial attention from the scientific community. The petition also highlighted the client's National Institutes of Health (NIH)-supported research, reinforcing the national significance of developing scalable, minimally invasive diagnostic technologies for neurological diseases.

USCIS approved the petition in July 2026, after just 2 months and 1 day under Premium Processing. We were pleased to help demonstrate how the client's accomplishments and future research plans support continued innovation in precision oncology and molecular diagnostics.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%